Welcome to the world of
greenovation Biotech Gmbh!

Our core competence

is the effective optimization and production of pharmaceutically highly-efficient glycoproteins in contained photo bioreactors.

The production platform

is based on bryotechnology (bryophytes = mosses), developed by greenovation. In this process mosses are genetically modified in a way that enables them to reproduce exactly the desired protein, for example an antibody for fighting cancer, according to a given blueprint.

Our main focus

is the production and optimization of cancer fighting antibodies as well as various other therapeutic proteins for different indications. We have already supplied our products to global customers for preclinical studies.